1. Home
  2. WAB vs BNTX Comparison

WAB vs BNTX Comparison

Compare WAB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAB
  • BNTX
  • Stock Information
  • Founded
  • WAB 1869
  • BNTX 2008
  • Country
  • WAB United States
  • BNTX Germany
  • Employees
  • WAB N/A
  • BNTX N/A
  • Industry
  • WAB Railroads
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WAB Industrials
  • BNTX Health Care
  • Exchange
  • WAB Nasdaq
  • BNTX Nasdaq
  • Market Cap
  • WAB 32.6B
  • BNTX 28.3B
  • IPO Year
  • WAB 1995
  • BNTX 2019
  • Fundamental
  • Price
  • WAB $184.63
  • BNTX $120.01
  • Analyst Decision
  • WAB Buy
  • BNTX Strong Buy
  • Analyst Count
  • WAB 8
  • BNTX 16
  • Target Price
  • WAB $188.75
  • BNTX $145.28
  • AVG Volume (30 Days)
  • WAB 1.2M
  • BNTX 735.7K
  • Earning Date
  • WAB 02-12-2025
  • BNTX 03-19-2025
  • Dividend Yield
  • WAB 0.54%
  • BNTX N/A
  • EPS Growth
  • WAB 33.05
  • BNTX N/A
  • EPS
  • WAB 6.04
  • BNTX N/A
  • Revenue
  • WAB $10,387,000,000.00
  • BNTX $3,390,698,192.00
  • Revenue This Year
  • WAB $7.29
  • BNTX N/A
  • Revenue Next Year
  • WAB $4.10
  • BNTX N/A
  • P/E Ratio
  • WAB $30.56
  • BNTX N/A
  • Revenue Growth
  • WAB 7.34
  • BNTX N/A
  • 52 Week Low
  • WAB $136.64
  • BNTX $76.53
  • 52 Week High
  • WAB $210.88
  • BNTX $131.49
  • Technical
  • Relative Strength Index (RSI)
  • WAB 35.79
  • BNTX 51.85
  • Support Level
  • WAB $185.03
  • BNTX $115.66
  • Resistance Level
  • WAB $193.69
  • BNTX $124.49
  • Average True Range (ATR)
  • WAB 5.17
  • BNTX 4.94
  • MACD
  • WAB -2.32
  • BNTX -0.01
  • Stochastic Oscillator
  • WAB 4.92
  • BNTX 65.37

About WAB Westinghouse Air Brake Technologies Corporation

Westinghouse Air Brake Technologies Corp is a provider of value-added, technology-based products and services for the freight rail and passenger transit industries, and the mining, marine, and industrial markets. It provides its products and services through two main business segments, Freight and Transit. The company generates maximum revenue from the Freight segment which manufactures new and modernized locomotives, provides aftermarket parts and services to existing locomotives; provides components to new and existing freight cars; builds new commuter locomotives; supplies rail control and infrastructure products including electronics, positive train control equipment, signal design and engineering services. Geographically, it generates a majority of its revenue from the United States.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Share on Social Networks: